Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease
Pritam Thapa, Sunil P. Upadhyay, William Z. Suo, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104681-104681
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry
Gayathri Rajendran, Deepu Bhanu, Baladhandapani Aruchamy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 68
Synthesis, characterization, biological evaluation, ADMET, and molecular docking studies of novel chalcone-sulfonate hybrid compounds as potential antioxidant and antiobesity activities
Adem Korkmaz, Ercan Bursal
Journal of Molecular Structure (2025), pp. 141638-141638
Closed Access | Times Cited: 1
Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation
Aso Hameed Hasan, Sankaranarayanan Murugesan, Syazwani Itri Amran, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105572-105572
Closed Access | Times Cited: 60
Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
Cheng‐Xin Gong, Chun‐Ling Dai, Fei Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 55
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 8
Echinatin protects from ischemic brain injury by attenuating NLRP3-related neuroinflammation
Liang Sun, Duo Chen, Chenchen Zhao, et al.
Neurochemistry International (2024) Vol. 175, pp. 105676-105676
Closed Access | Times Cited: 7
Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
Alfred Ngenge Tamfu, Selçuk Küçükaydın, Balakyz Yeskaliyeva, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5582-5582
Open Access | Times Cited: 46
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors
Wenjing Liu, Min He, Yongjun Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 37, Iss. 1, pp. 9-38
Open Access | Times Cited: 44
An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects
Melford C. Egbujor, Brigitta Buttari, Elisabetta Profumo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8466-8466
Open Access | Times Cited: 31
Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones
Teodora Constantinescu, Alin Grig Mihis
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11595-11595
Open Access | Times Cited: 29
Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease
Rui Chen, Xinjuan Li, Hongsong Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115253-115253
Closed Access | Times Cited: 16
Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease
Nilesh Gajanan Bajad, Ravi Bhushan Singh, Gajendra T.A., et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107082-107082
Closed Access | Times Cited: 5
NOVEL HETEROCYCLIC HYBRIDS AS PROMISING SCAFFOLD FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE
Tyagi Alka
International Journal of Pharmacy and Pharmaceutical Sciences (2025), pp. 1-15
Open Access
Multi-targeted Thiophene Based Effective Digestive Enzyme Inhibitors: Synthesis and Enzyme Inhibition Studies
Prabhjot Kaur, Neera Raghav, Urmila Berar
Journal of Molecular Structure (2025), pp. 141748-141748
Closed Access
Phytomolecules as Alzheimer’s Therapeutics: A Comprehensive Review
Mohd Kamil Hussain, Mafaz Ahmad, Shahnaaz Khatoon, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117401-117401
Closed Access
A Facile and Rapid Method for Synthesizing Indole–Chalcone Hybrids
Solange Ayukncha Tanyi, Donatus Bekindaka Eni, Mohamed Abdelsalam, et al.
Molbank (2025) Vol. 2025, Iss. 1, pp. M1974-M1974
Open Access
A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives
Sri Mounika Bellapukonda, Rani Bandela, Anuradha Singampalli, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117472-117472
Closed Access
Hydroxy Chalcones and Analogs with Chemopreventive Properties
M. L. Birsa, Laura G. Sârbu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10667-10667
Open Access | Times Cited: 14
Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study
Tarek S. Ibrahim, Ahmad J. Almalki, Amr H. Moustafa, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104885-104885
Closed Access | Times Cited: 31
Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 847-847
Open Access | Times Cited: 20
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
Pritam Thapa, Sunil P. Upadhyay, Vikas Singh, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 7, pp. 100100-100100
Open Access | Times Cited: 19
Synthesis, antibacterial, antifungal and computational study of (E)-4-(3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-oxoprop-1-en-1-yl)benzonitrile
Rahul A. Shinde, Vishnu A. Adole, Rohit S. Shinde, et al.
Results in Chemistry (2022) Vol. 4, pp. 100553-100553
Open Access | Times Cited: 18
Horner–Wadsworth–Emmons reaction as an excellent tool in the synthesis of fluoro-containing biologically important compounds
Monika Bilska‐Markowska, Marcin Kaźmierczak
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 6, pp. 1095-1120
Closed Access | Times Cited: 11
In Silico Study in MPO and Molecular Docking of the Synthetic Drynaran Analogues Against the Chronic Tinnitus: Modulation of the M1 Muscarinic Acetylcholine Receptor
Matheus Nunes da Rocha, Aluísio Marques da Fonseca, Adriana Nogueira Machado Dantas, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 2, pp. 254-269
Closed Access | Times Cited: 10
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top